Highlights and Quick Summary
- Capex/Depreciation for the quarter ending December 31, 2022 was 0.0 (a NaN% decrease compared to previous quarter)
- Year-over-year quarterly Capex/Depreciation decreased by NaN%
- Annual Capex/Depreciation for 2022 was -0.08 (a -Infinity% decrease from previous year)
- Annual Capex/Depreciation for 2022 was 0.0 (a -100.0% decrease from previous year)
- Annual Capex/Depreciation for 2021 was -0.96 (a -Infinity% decrease from previous year)
- Twelve month Capex/Depreciation ending December 31, 2022 was 0.0 (a NaN% decrease compared to previous quarter)
- Twelve month trailing Capex/Depreciation decreased by NaN% year-over-year
Trailing Capex/Depreciation for the last four month:
| 31 Dec '22 | 30 Sep '22 | 30 Jun '22 | 31 Mar '22 |
|---|---|---|---|
| 0.0 | 0.0 | -0.37 | 0.0 |
Visit stockrow.com/BNTC
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Capex/Depreciation of Benitec Biopharma Limited
Most recent Capex/Depreciationof BNTC including historical data for past 10 years.Interactive Chart of Capex/Depreciation of Benitec Biopharma Limited
Benitec Biopharma Limited Capex/Depreciation for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | 0.0 | 0.0 | -2.17 | 0.0 | -0.08 |
| 2021 | 0.0 | 0.0 | 2.71 | -0.22 | -0.96 |
| 2020 | -2.6 | -3.84 | -0.33 | -0.01 | -0.49 |
| 2019 | – | – | -0.84 | 0.02 | -2.53 |
| 2018 | – | – | – | – | -0.42 |
| 2017 | – | – | – | 0.0 | 0.0 |
| 2016 | – | 0.0 | -0.48 | 0.0 | -1.18 |
| 2015 | – | – | 0.0 | -5.25 | -5.21 |
| 2014 | – | – | 0.0 | -2.0 | -2.52 |
| 2013 | -0.33 | – | – | – | -0.33 |
Business Profile of Benitec Biopharma Limited
Sector: Healthcare
Industry: Biotechnology